1.
Chinese Journal of Interventional Imaging and Therapy
;
(12): 57-60, 2019.
Artigo
em Chinês
| WPRIM
| ID: wpr-862191
RESUMO
Hepatocellular carcinoma (HCC) is one of the most common malignant tumors. Up till now, TACE is the first choice for palliative treatment of HCC. In recent years, a series of metabolites of HCC have been found in the proteome and mRNA groups. The value of common and hot research on tumor markers in HCC for the treatment of TACE were reviewed in this article.